Dr Luke Grzeskowiak is an Associate Professor (Practitioner Fellow) and Channel 7 Children's Research Foundation Fellow in Medicines Use and Safety based at Flinders University where he leads the Reproductive and Perinatal Pharmacoepidemiology Research Group. He also holds a conjoint position at SAHMRI Women and Kids and is a Senior Pharmacist in Women’s and Newborn Health at Flinders Medical Centre. His research focuses on evaluating the use and effects of medicines and other substances related to women’s and children’s health. His overarching clinical and research ambitions are to improve the health of women and children through the development and promotion of safer, more effective and personalised approaches to pharmacotherapy. Core research themes of his group include:

- Understanding and influencing medicines use: Understanding and influencing key aspects related to medication utilisation in clinical practice to enhance decision-making, address evidence-practice gaps and improve research translation

- Enhancing medication safety: Enhancing our understanding of the immediate and long-term risks associated with medication use and creating safer systems to reduce medication related harms

- Improving pharmacotherapeutics: Developing and promoting more efficacious and personalised pharmacotherapy approaches for improving reproductive and perinatal health

He is a recognised national expert on medication use in pregnancy and lactation and serves as an expert reviewer for the Australian Therapeutic Guidelines. He has been invited to speak at more than 20 national and international conferences and is regularly involved in undergraduate and postgraduate education programs. He has a strong commitment to community engagement and inclusive research practices, partnering with a number of consumer organisations across a range of projects. His research is also supported by longstanding, productive collaborations with clinicians across hospital and primary health care settings. His research has been supported by $9.7 million in grant funding ($3 million as the first-named Investigator) across 24 grants and has received funding from the National Health and Medical Research Council and Medical Research Future Fund. He has received grants from prestigious, including a NHMRC Early Career Fellowship. His research has led to publications in top-ranking journals such as PLOS Medicine, Medical Journal of Australia, European Research Journal, British Journal of Obstetrics and Gynaecology, and Human Reproduction. Research undertaken by his group has had a significant positive effect in influencing practice guidelines and clinical care at the local, national, and international level.